MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors

Theranostics

Volumn 5, Issue 5, 2015, Pages 477-488

  Kim, Dong Hyun ^a   Chen, Jeane ^a   Omary, Reed A ^b   Larson, Andrew C ^a,c,d,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Department of Bioengineering University of Illinois at Chicago ^*  (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Liver tumors; Microspheres; MRI

Indexed keywords

ALGINATE MICROSPHERE; AMONAFIDE; IOHEXOL; MICROSPHERE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; ALGINIC ACID; ANTINEOPLASTIC AGENT; DRUG CARRIER; GLUCURONIC ACID; HEXURONIC ACID; NAPHTHALIMIDE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; CANCER INHIBITION; CATHETER DIRECTED DRUG DELIVERY; CONTROLLED STUDY; DISEASE MODEL; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; GELATION; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; MICROFLUIDICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SUSTAINED DRUG RELEASE; SYNTHESIS; TREATMENT OUTCOME; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER NEOPLASMS; PATHOLOGY; PROCEDURES;

ALGINATES; ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; GLUCURONIC ACID; HEXURONIC ACIDS; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICROSPHERES; NAPHTHALIMIDES; RATS;

EID: 84930203372     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.10823     Document Type: Article

References (35)

1. Ackerman NB. Experimental studies on the circulation dynamics of intrahepatic tumor blood supply. Cancer. 1972; 29: 435-9.
2. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovascular and interventional radiology. 2007; 30: 6-25. doi:10.1007/s00270-006-0062-3.
3. Biolato M, Marrone G, Racco S, Di Stasi C, Miele L, Gasbarrini G, et al. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?. European review for medical and pharmacological sciences. 2010; 14: 356-62.
4. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. Journal of surgical oncology. 2000; 73: 109-14.
5. Trinchet JC, Ganne-Carrie N, Beaugrand M. Intra-arterial chemoembolization in patients with hepatocellular carcinoma. Hepato-gastroenterology. 1998; 45 Suppl 3: 1242-7.
6. Song MJ, Chun HJ, Song DS, Kim HY, Yoo SH, Park CH, et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol. 2012; 57: 1244-50.
7. Gonzalez MV, Tang YQ, Phillips GJ, Lloyd AW, Hall B, Stratford PW, et al. Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro: in-vivo correlation. J Mater Sci-Mater M. 2008; 19: 767-75. doi:Doi 10.1007/S10856-006-0040-Y.
8. Taningher M, Malacarne D, Izzotti A, Ugolini D, Parodi S. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res-Rev Mutat. 1999; 436: 227-61.
9. Felder TB, Mclean MA, Vestal ML, Lu K, Farquhar D, Legha SS, et al. Pharmacokinetics and Metabolism of the Antitumor Drug Amonafide (Nsc-308847) in Humans. Drug Metab Dispos. 1987; 15: 773-8.
10. Denkbas EB, Seyyal M, Piskin E. 5-fluorouracil loaded chitosan microspheres for chemoembolization. Journal of microencapsulation. 1999; 16: 741-9. doi:10.1080/026520499288681.
11. Liu X, Heng WS, et al. Novel polymeric microspheres containing norcantharidin for chemoembolization. Journal of controlled release: official journal of the Controlled Release Society. 2006; 116: 35-41. doi:10.1016/j.jconrel.2006.08.022.
12. Osuga K, Arai Y, Anai H, Takeuchi Y, Aramaki T, Sugihara E, et al. Phase I/II multicenter study of transarterial chemoembolization with a cisplatin fine powder and porous gelatin particles for unresectable hepatocellular carcinoma: Japan Interventional Radiology in Oncology Study Group Study 0401. Journal of vascular and interventional radiology: JVIR. 2012; 23: 1278-85. doi:10.1016/j.jvir.2012.06.028.
13. Morise Z, Sugioka A, Kato R, Fujita J, Hoshimoto S, Kato T. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2006; 10: 249-58. doi:10.1016/j.gassur.2005.08.004.
14. Fu S, Thacker A, Sperger DM, Boni RL, Buckner IS, Velankar S, et al. Relevance of rheological properties of sodium alginate in solution to calcium alginate gel properties. AAPS PharmSciTech. 2011; 12: 453-60. doi:10.1208/s12249-011-9587-0.
15. Thu B, Bruheim P, Espevik T, Smidsrod O, SoonShiong P, SkjakBraek G. Alginate polycation microcapsules.1. Interaction between alginate and polycation. Biomaterials. 1996; 17: 1031-40. doi:Doi 10.1016/0142-9612(96)84680-1.
16. Zuidam NJ, Nedović V. Encapsulation technologies for active food ingredients and food processing. New York; London: Springer; 2009.
17. Ge JP, Hu YX, Biasini M, Beyermann WP, Yin YD. Superparamagnetic magnetite colloidal nanocrystal clusters. Angew Chem Int Edit. 2007; 46: 4342-5.
18. Kim DH, Guo Y, Zhang Z, Procissi D, Nicolai J, Omary RA, et al. Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia. Advanced healthcare materials. 2014; 3: 714-24. doi:10.1002/adhm.201300209.
19. Ono Y, Yoshimasu T, Ashikaga R, Inoue M, Shindou H, Fuji K, et al. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. American journal of clinical oncology. 2000; 23: 564-8.
20. Johnson PJ, Kalayci C, Dobbs N, Raby N, Metivier EM, Summers L, et al. Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol. Journal of hepatology. 1991; 13: 120-7.
21. Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL, et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. Journal of vascular and interventional radiology: JVIR. 2006; 17: 335-42. doi:10.1097/01.RVI.0000195323.46152.B3.
22. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 1997; 8: 117-36.
23. Mikhaylov G, Mikac U, Magaeva AA, Itin VI, Naiden EP, Psakhye I, et al. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotechnol. 2011; 6: 594-602.
24. Paquet C, de Haan HW, Leek DM, Lin HY, Xiang B, Tian GH, et al. Clusters of Superparamagnetic Iron Oxide Nanoparticles Encapsulated in a Hydrogel: A Particle Architecture Generating a Synergistic Enhancement of the T-2 Relaxation. Acs Nano. 2011; 5: 3104-12.
25. Kim DH, Choy T, Huang S, Green RM, Omary RA, Larson AC. Microfluidic fabrication of 6-methoxyethylamino numonafide-eluting magnetic microspheres. Acta biomaterialia. 2014; 10: 742-50. doi:10.1016/j.actbio.2013.10.018.
26. Lemoine D, Wauters F, Bouchend'homme S, Preat V. Preparation and characterization of alginate microspheres containing a model antigen. Int J Pharmaceut. 1998; 176: 9-19.
27. Joshi A, Solanki S, Chaudhari R, Bahadur D, Aslam M, Srivastava R. Multifunctional alginate microspheres for biosensing, drug delivery and magnetic resonance imaging. Acta Biomater. 2011; 7: 3955-63.
28. Chen WY, Kim JH, Zhang D, Lee KH, Cangelosi GA, Soelberg SD, et al. Microfluidic one-step synthesis of alginate microspheres immobilized with antibodies. J R Soc Interface. 2013; 10. doi:10.1098/Rsif.2013.0566.
29. Pessi J, Santos HA, Miroshnyk I, et al. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery. International journal of pharmaceutics. 2014; 472: 82-7. doi:10.1016/j.ijpharm.2014.06.012.
30. Xu Q, Hashimoto M, Dang TT, Hoare T, Kohane DS, Whitesides GM, et al. Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small. 2009; 5: 1575-81. doi:10.1002/smll.200801855.
31. Lagus TP, Edd JF. A review of the theory, methods and recent applications of high-throughput single-cell droplet microfluidics. J Phys D Appl Phys. 2013;46. doi:10.1088/0022-3727/46/11/114005.
32. Liu YN, Norton JT, Witschi MA, Xu Q, Lou GH, Wang C, et al. Methoxyethylamino-numonafide Is an Efficacious and Minimally Toxic Amonafide Derivative in Murine Models of Human Cancer. Neoplasia. 2011; 13: 453-60.
33. Allen SL, Lundberg AS. Amonafide: a potential role in treating acute myeloid leukemia. Expert opinion on investigational drugs. 2011; 20: 995-1003. doi:10.1517/13543784.2011.585756.
34. Kornek G, Raderer M, Depisch D, Haider K, Fazeny B, Dittrich C, et al. Amonafide as First-Line Chemotherapy for Metastatic Breast-Cancer. Eur J Cancer. 1994; 30A: 398-400.
35. Innocenti F, Iyer L, Ratain MJ. Pharmacogenetics of anticancer agents: Lessons from amonafide and irinotecan. Drug Metab Dispos. 2001; 29: 596-600.